Stockscreener 앱 받기
210.26
0.16%
-0.625
전일 마감가:
$210.89
열려 있는:
$210.82
하루 거래량:
455.09K
Relative Volume:
0.63
시가총액:
$15.11B
수익:
$2.90B
순이익/손실:
$467.20M
주가수익비율:
33.01
EPS:
6.37
순현금흐름:
$306.90M
1주 성능:
-6.21%
1개월 성능:
-2.44%
6개월 성능:
-38.91%
1년 성능:
-33.77%
1일 변동 폭
$208.71
$213.44
1주일 범위
$206.80
$226.50
52주 변동 폭
$187.43
$352.33
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
WST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
210.35 | 16.13B | 2.90B | 467.20M | 306.90M | 6.37 |
|
ISRG
Intuitive Surgical Inc
|
516.38 | 185.10B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
175.96 | 50.76B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.31 | 43.19B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
261.11 | 37.26B | 5.02B | 1.31B | 1.56B | 8.91 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
West pharmaceutical services appoints Robert McMahon as new CFO - Investing.com
Healthcare Veteran Robert McMahon Exits Agilent to Lead West Pharma's Financial Future - Stock Titan
Is West Pharmaceutical Services Inc. a good long term investmentConsistently outstanding ROI - Autocar Professional
Mutual of America Capital Management LLC Sells 252 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
What drives West Pharmaceutical Services Inc. stock priceUnbelievable profit margins - Autocar Professional
West Pharmaceutical Services Inc (WST) Stock Down 4.76% on July 18th - AInvest
West Pharmaceutical Services Inc. Stock Analysis and ForecastExplosive capital gains - jammulinksnews.com
West Pharmaceutical Services to Announce Q2 2025 Results and Host Live Conference Call - MSN
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MSN
Bank of America Securities Keeps Their Buy Rating on West Pharmaceutical Services (WST) - The Globe and Mail
What analysts say about West Pharmaceutical Services Inc. stockUnrivaled growth potential - jammulinksnews.com
Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know - TradingView
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory - MSN
Can West Pharmaceutical Services Inc. stock recover from recent declineChart Based Entries - Newser
Allworth Financial LP Has $96,000 Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
How West Pharmaceutical Services Inc. stock performs during market volatilityFree Stock Portfolio Optimization - Newser
West Pharmaceutical Services (WST) to Release Quarterly Earnings on Thursday - Defense World
Strategy To YieldBoost West Pharmaceutical Services From 0.4% To 13.2% Using Options - Nasdaq
Why West Pharmaceutical Services Inc. stock attracts strong analyst attentionFree Stock Index Interpretation - Newser
What makes West Pharmaceutical Services Inc. stock price move sharplyHigh Confidence Trade Setups - Newser
Drug Development Inputs & Services Stocks Q1 Results: Benchmarking West Pharmaceutical Services (NYSE:WST) - Yahoo Finance
Is West Pharmaceutical Services (WST) a Great Business Unfairly Sold Off by the Market? - Insider Monkey
Here's Why West Pharmaceutical Services (NYSE:WST) Can Manage Its Debt Responsibly - simplywall.st
Cambridge Investment Research Advisors Inc. Sells 281 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
Sustainable Pharmaceutical Packaging Market to Reach USD 299.95 billion by 2032 - newstrail.com
Allspring Global Investments Holdings LLC Sells 251 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
WEST ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
West Pharmaceutical Services’ Q2 2025 Earnings: What to Expect - MSN
West to Host Second-Quarter 2025 Conference Call - The Malaysian Reserve
DAVENPORT & Co LLC Has $499,000 Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Services, Inc. (WST) LawsuitInvestors Urged to Contact Levi & Korsinsky Before July 7, 2025 - ACCESS Newswire
Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
West Pharmaceutical Services, Inc. Sued for Securities Law - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming DeadlinesWST - cnhinews.com
Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST)Levi & Korsinsky Reminds Investors of July 7, 2025 - ACCESS Newswire
WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm - WV News
West Pharmaceutical Services Faces Securities Class Action Lawsuit Allegations. - AInvest
Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Seeking Recovery for InvestorsContact The Gross Law Firm - The Victoria Advocate
Vontobel Holding Ltd. Sells 206 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
Contact The Gross Law Firm by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc.(WST) - Finansavisen
WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsWST - WV News
Investors in West Pharmaceutical Services, Inc. (WST): Protect Your RightsContact Levi & Korsinsky Before July 7, 2025 - ACCESS Newswire
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates - GlobeNewswire
GAMMA Investing LLC Cuts Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.48%
0.63%
자본화:
|
볼륨(24시간):